This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: HLS Therapeutics Inc.

Baystreet.ca - Baystreet - Wed Jul 29, 8:57AM CDT

Announces that it will release financial results for the three and six months ended June 30, 2026, on Wednesday, August 12. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $4.21.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).